121 related articles for article (PubMed ID: 22663383)
1. Decorin promotes myogenic differentiation and mdx mice therapeutic effects after transplantation of rat adipose-derived stem cells.
Geng J; Liu G; Peng F; Yang L; Cao J; Li Q; Chen F; Kong J; Pang R; Zhang C
Cytotherapy; 2012 Aug; 14(7):877-86. PubMed ID: 22663383
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of myostatin promotes myogenic differentiation of rat bone marrow-derived mesenchymal stromal cells.
Geng J; Peng F; Xiong F; Shang Y; Zhao C; Li W; Zhang C
Cytotherapy; 2009; 11(7):849-63. PubMed ID: 19903098
[TBL] [Abstract][Full Text] [Related]
3. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice.
Feng SW; Lu XL; Liu ZS; Zhang YN; Liu TY; Li JL; Yu MJ; Zeng Y; Zhang C
Cytotherapy; 2008; 10(3):254-64. PubMed ID: 18418771
[TBL] [Abstract][Full Text] [Related]
4. Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle.
Tsao J; Vernet DA; Gelfand R; Kovanecz I; Nolazco G; Bruhn KW; Gonzalez-Cadavid NF
Stem Cell Res Ther; 2013 Jan; 4(1):4. PubMed ID: 23295128
[TBL] [Abstract][Full Text] [Related]
5. BMP4 inhibits myogenic differentiation of bone marrow-derived mesenchymal stromal cells in mdx mice.
Jiqing C; Yaqin L; Yingyin L; Fei C; Huili Z; Yuling Z; Juan Y; Shanwei F; Cheng Z
Cytotherapy; 2015 Sep; 17(9):1213-9. PubMed ID: 26276004
[TBL] [Abstract][Full Text] [Related]
6. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
Fakhfakh R; Michaud A; Tremblay JP
Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
[TBL] [Abstract][Full Text] [Related]
7. Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice.
Zhang Y; Zhu Y; Li Y; Cao J; Zhang H; Chen M; Wang L; Zhang C
Hum Mol Genet; 2015 Nov; 24(21):6029-40. PubMed ID: 26264578
[TBL] [Abstract][Full Text] [Related]
8. Myostatin-null mice exhibit delayed skin wound healing through the blockade of transforming growth factor-β signaling by decorin.
Zhang C; Tan CK; McFarlane C; Sharma M; Tan NS; Kambadur R
Am J Physiol Cell Physiol; 2012 Apr; 302(8):C1213-25. PubMed ID: 22277753
[TBL] [Abstract][Full Text] [Related]
9. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt3a signaling promotes myogenic differentiation of mesenchymal stem cells in mdx mice.
Shang YC; Wang SH; Xiong F; Peng FN; Liu ZS; Geng J; Zhang C
Acta Pharmacol Sin; 2016 Jul; 37(7):873-81. PubMed ID: 27133298
[TBL] [Abstract][Full Text] [Related]
11. Stem cells isolated from human dental pulp and amniotic fluid improve skeletal muscle histopathology in mdx/SCID mice.
Pisciotta A; Riccio M; Carnevale G; Lu A; De Biasi S; Gibellini L; La Sala GB; Bruzzesi G; Ferrari A; Huard J; De Pol A
Stem Cell Res Ther; 2015 Aug; 6(1):156. PubMed ID: 26316011
[TBL] [Abstract][Full Text] [Related]
12. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
[TBL] [Abstract][Full Text] [Related]
14. [Dystrophin expression and pathology of diaphragm muscles of mdx mice after xenogenic bone marrow stem cell transplantation].
Zhang YN; Zhang C; Yu MJ; Wang SH; Li MS; Huang H; Xiong F; Feng SW; Liu TY; Lu XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):53-8. PubMed ID: 16495176
[TBL] [Abstract][Full Text] [Related]
15. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of decorin during the regeneration stage of mdx mouse.
Abe S; Hirose D; Kado S; Iwanuma O; Saka H; Yanagisawa N; Ide Y
Anat Sci Int; 2009 Dec; 84(4):305-11. PubMed ID: 19337786
[TBL] [Abstract][Full Text] [Related]
17. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle.
Hammers DW; Hart CC; Patsalos A; Matheny MK; Wright LA; Nagy L; Sweeney HL
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31830002
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo analysis of human fibroblast reprogramming and multipotency.
Pang R; Zhu X; Geng J; Zhang Y; Wang Q; He J; Wang J; Zhu G; Xiong F; Zhang C; Ruan G; Pan X
Cell Mol Biol Lett; 2015 Sep; 20(3):404-17. PubMed ID: 26208388
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of myostatin, follistatin and decorin expression in muscle of different origin.
Hiroki E; Abe S; Iwanuma O; Sakiyama K; Yanagisawa N; Shiozaki K; Ide Y
Anat Sci Int; 2011 Sep; 86(3):151-9. PubMed ID: 21416223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
